1. Home
  2. STTK vs TWIN Comparison

STTK vs TWIN Comparison

Compare STTK & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.07

Market Cap

275.9M

Sector

Health Care

ML Signal

HOLD

Logo Twin Disc Incorporated

TWIN

Twin Disc Incorporated

N/A

Current Price

$15.53

Market Cap

269.7M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
STTK
TWIN
Founded
2016
1918
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
275.9M
269.7M
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
STTK
TWIN
Price
$6.07
$15.53
Analyst Decision
Buy
Strong Buy
Analyst Count
7
1
Target Price
$7.60
$12.00
AVG Volume (30 Days)
674.5K
33.9K
Earning Date
03-05-2026
05-06-2026
Dividend Yield
N/A
1.04%
EPS Growth
53.02
N/A
EPS
N/A
1.53
Revenue
$1,000,000.00
$340,738,000.00
Revenue This Year
N/A
$10.79
Revenue Next Year
N/A
$8.43
P/E Ratio
N/A
$10.06
Revenue Growth
N/A
15.45
52 Week Low
$0.69
$6.16
52 Week High
$6.81
$19.63

Technical Indicators

Market Signals
Indicator
STTK
TWIN
Relative Strength Index (RSI) 64.13 42.69
Support Level $1.85 $14.80
Resistance Level N/A $16.62
Average True Range (ATR) 0.37 0.76
MACD -0.02 0.03
Stochastic Oscillator 40.42 36.11

Price Performance

Historical Comparison
STTK
TWIN

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

Share on Social Networks: